Case report: Successful treatment with tofacitinib and colchicine in a patient with Schnitzler syndrome

被引：4
|
作者：
Li, Man [1 ]
Chen, Yu-Wen [2 ]
Shen, Amy [3 ]
Xie, Yong-Xin [1 ]
Wu, Yonglan [1 ]
Zeng, Xianlin [1 ]
Leong, Pui-Ying [4 ,5 ,6 ]
机构：
[1] Second Hosp Longyan, Dept Rheumatol, Longyan, Peoples R China
[2] Taichung Vet Gen Hosp, Dept Dermatol, Taichung, Taiwan
[3] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
[4] Chung Shan Med Univ Hosp, Dept Internal Med, Div Allergy Immunol & Rheumatol, Taichung, Taiwan
[5] Chung Shan Med Univ, Inst Med, Taichung, Taiwan
[6] Chung Shan Med Univ, Sch Med, Taichung, Taiwan
来源：
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES | 2023年 / 26卷 / 01期
关键词：
anti-IL1 and anti-IL6; JAK inhibitors; Schnitzler syndrome;
D O I：
10.1111/1756-185X.14457
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
We report a case of late-onset Schnitzler syndrome successfully treated with Janus-activated kinase (JAK) inhibitors and colchicine. Schnitzler syndrome should be considered for recurrent chronic urticaria when accompanied by fever, fatigue, rapid weight loss, and poor response to antihistamine treatment. Skin biopsy, bone marrow biopsy, and electrophoresis help confirm the diagnosis. Early diagnosis and treatment can lead to complete resolution of symptoms. Besides interleukin (IL)-1 and IL-6 inhibitors, JAK inhibitors and colchicine may be considered as other choices of treatment.
引用
收藏
页码：160 / 163
页数：4
相关论文
共 50 条
  • [1] Case report: successful treatment of refractory SAPHO syndrome with the JAK inhibitor tofacitinib
    Yang, Qiao
    Zhao, Yumo
    Li, Chen
    Luo, Yaping
    Hao, Weixin
    Zhang, Wen
    MEDICINE, 2018, 97 (25)
  • [2] Successful treatment of Schnitzler syndrome with cyclosporine
    Nakajima, Kimiko
    Takahashi, Masato
    Yamamoto, Mayuko
    Takahashi, Aya
    Sano, Shigetoshi
    Kodama, Hajime
    Arima, Kazuhiko
    Ida, Hiroaki
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2014, 53 (07) : e361 - e363
  • [3] Case report: Therapeutic use of bortezomib in a patient with Schnitzler syndrome
    Bai, Hua
    Zhou, Dongming
    Liu, Jinwen
    He, Jie
    Min, Zhou
    Fan, Wenyong
    Chen, Bing
    Xu, Yong
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [4] Case Report: Therapeutic Use of Ibrutinib in a Patient With Schnitzler Syndrome
    Huang, Yuehua
    Wang, Yanying
    Yu, Fan
    Mao, Xuehan
    Wang, Bianhong
    Li, Jingxian
    Li, Lihong
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [5] Successful treatment with rituximab in patients with Schnitzler syndrome
    Novikov, P.
    Kuznetsova, E.
    Pulina, V.
    Meshkov, A.
    Nikiforova, N.
    PRESSE MEDICALE, 2013, 42 (04): : 738 - 738
  • [6] Schnitzler's syndrome: Successful treatment with anakinra
    Crouch, Rohan
    Akhras, Victoria
    Sarkany, Robert
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2007, 48 (03) : 178 - 181
  • [7] Successful treatment of pediatric patient with Dravet syndrome with cenobamate: Case report
    Lobanov, Oleg, V
    Bertrand, Mary
    SAGE OPEN MEDICAL CASE REPORTS, 2025, 13
  • [8] Successful Treatment of Refractory Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis (SAPHO) Syndrome With Tofacitinib: A Case Report
    Alhayali, Mustafa
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (08)
  • [9] Schnitzler syndrome: a case report of successful treatment using the anti-CD20 monoclonal antibody rituximab
    Ramadan, K. M.
    Eswedi, H. A.
    El-Agnaf, M. R.
    BRITISH JOURNAL OF DERMATOLOGY, 2007, 156 (05) : 1072 - 1074
  • [10] Schnitzler syndrome: A new case report
    Latour-Alvarez, Irene
    Vazquez-Rodriguez, Cristina
    Garcia-Peris, Estela
    Arteaga-Henriquez, Maria
    Markthaler, Marcella
    Lukoviek, Vania
    Jose Guimera-Martin-Neda, Francisco
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : AB226 - AB226
12345